Firm Receives Funding for Clinical Trials of New Medical Therapies

360 million people worldwide suffer from hearing loss. Our team of scientists and researchers at Ting Therapeutics discovered that there are new drugs that could potentially prevent hearing loss.

A Vision For Hearing Research

Dr. Jian Zuo, the CEO, and founder of Ting Therapeutics is also the head of the drug design for the Translational Hearing Center in Omaha, Nebraska. He works with Dr. Peter Styger to develop the first drug that could prevent chemotherapy drug-associated hearing loss in children.